BioXmark – Clinical studies
We aim for BioXmark® to become an integrated part of cancer patient treatment workflows, enabling high precision of radiation therapy and supporting interventional oncology.
To demonstrate the value of our liquid fiducial marker for high-precision therapy, we collaborate with healthcare professionals on clinical research projects across cancer types. The results of these clinical collaborations are disseminated through independent scientific channels to increase the awareness and understanding of the possibilities offered by BioXmark to improve therapeutic precision for better outcomes.
If you are interested in a clinical collaboration to further exploit the potential of BioXmark to guide high precision cancer therapy, do not hesitate to contact us.
See below for references and links to clinical publications per cancer type. At the bottom of the page you find a link to download a complete list of BioXmark® study publications.
Head & neck cancer
See or download a complete list of BioXmark® study publications: BioXmark publications list